Tag Archives: Health Care

Partners for Healthy Dialogues: Letter to CMS

Partners for Health Dialogues

BIO, a member of Partners for Healthy Dialogues (P4HD), joined 25 medical societies and manufacturers in a letter to the Center for Medicare and Medicaid Services highlighting both their shared commitment to sunshine and the importance of context in the upcoming data release.  As BIO CEO Jim Greenwood said in a Q&A with P4HD: “We believe that part of CMS’s public service function in this area should be to help improve the public’s understanding of the need for Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

New Report: Innovation in Hepatitis C Treatment

chi-logo-small

Today, the California Healthcare Institute released a report on the public health impact of Hepatitis C and the potential of groundbreaking new treatments to save tens of thousands of lives over the coming decades. Innovation in Hepatitis C Treatment: New Opportunities for Action explores the incredible progress that has been made in Hepatitis C treatment in the decades since the Hepatitis C virus was identified as the cause of the disease in 1989. Early treatments Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BioCentury TV This Week: 340B Drug Discount Program Needs More Oversight

Todd

BIO’s Laurel Todd shared concerns that the 340B program has departed significantly from its original intent, leading to evidence of abuse and potentially harmful consequences for patients. “The original intent of 340B was to support the most vulnerable patients; clearly that is not the focus for many of the participants in the program now,” said Todd. Todd pointed to three primary reasons the program needs more oversight: Exponential growth, significant violations revealed in audits, and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Beggar-Thy-Neighbor Medicine: Wall Street Journal Op-Ed

medicine-thumb

In an editorial about specialty drug prices, the Wall Street Journal writes: “To understand how ObamaCare is already bending the future of U.S. medical progress, consult the furor over specialty drug prices, as an alliance of convenience among third-party payers assails pharmaceutical innovation as too costly. Maybe patients should give up on cures and, as President Obama once put it, just take the painkiller…” Read the full opinion

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Jim Greenwood Talks 21st Century Cures with Chairman Fred Upton

21st-Century-Cures--Free

Recently, BIO CEO and President Jim Greenwood sat down with House Energy and Commerce Chairman Fred Upton (R-MI) to talk about the Committee’s 21st Century Cures initiative, which seeks to “determine what steps we can take to ensure we are taking full advantage of the advances this country has made in science” to speed and improve drug discovery, development and delivery.  This is a bipartisan effort Chairman Upton and the committee are undertaking with the Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,